Show simple item record

dc.rights.licenseOpen Access
dc.rights.licenseA full text version is available in DSpace@RPI
dc.contributor.authorFath, M.A.
dc.contributor.authorWu, X.
dc.contributor.authorHileman, R.E.
dc.contributor.authorLinhardt, Robert J.
dc.contributor.authorAbraham, W.M.
dc.contributor.authorKashem, M.A.
dc.contributor.authorNelson, R.M.
dc.contributor.authorWright, C.
dc.date1998
dc.date.accessioned2022-06-26T20:43:49Z
dc.date.available2022-06-26T20:43:49Z
dc.date.issued1998
dc.identifier.citationInteraction of Secretory Leukocyte Protease Inhibitor with HeparinInhibits Proteases Involved in Asthma, M.A. Fath, X. Wu, R.E. Hileman,R.J. Linhardt, W.M. Abraham, M.A. Kashem, R.M. Nelson, and C.Wright, Journal of Biological Chemistry, 273, 13563-13569, 1998.
dc.identifier.urihttps://doi.org/10.1074/jbc.273.22.13563
dc.descriptionJournal of Biological Chemistry, 273, 13563-13569
dc.descriptionNote : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform.
dc.description.abstractProtease inhibition by secretory leukocyte protease inhibitor (SLPI) is accelerated by the sulfated polysaccharides. The nature of the SLPI-polysaccharide interaction, explored with affinity chromatography, indicated that this interaction was sensitive to the charge and type of polysaccharide. Dextran and chondroitin had the lowest affinity for SLPI, followed by dermatan, heparan, and dextran sulfates. While heparin bound SLPI tightly, the highest affinity heparin chains unexpectedly contained a lower level of sulfation than more weakly interacting chains. Heparin oligosaccharides, prepared using heparin lyase I were SLPI-affinity fractionated. Surprisingly, undersulfated heparin oligosaccharides bound SLPI with the highest affinity, suggesting the importance of free hydroxyl groups for high affinity interaction. Isothermal titration calorimetry was used to determine the thermodynamics of SLPI interaction with a low molecular weight heparin, an undersulfated decasaccharide and a tetrasaccharide. The studies showed 12-14 saccharide units, corresponding to molecular weight of approximately 4,800, were required for a 1:1 (SLPI:heparin) binding stoichiometry. Furthermore, an undersulfated decasaccharide was able to bind SLPI tightly (Kd approximately 13 nM), resulting in its activation and the inhibition of neutrophil elastase and pancreatic chymotrypsin. The in vitro assessment of heparin and the decasaccharide and tetrasaccharide using stopped-flow kinetics suggested that heparin was the optimal choice to study SLPI-based in vivo protease inhibition. SLPI and heparin were co-administered by inhalation in therapy against antigen-induced airway hyperresponsiveness in a sheep bronchoprovocation model. Heparin, in combination with SLPI demonstrated in vivo efficacy reducing early and late phase bronchoconstriction. Heparin also increased the therapeutic activity of SLPI against antigen-induced airway hyperresponsiveness.
dc.languageENG
dc.language.isoen_US
dc.publisherElsevier
dc.relation.ispartofThe Linhardt Research Labs Online Collection
dc.relation.ispartofRensselaer Polytechnic Institute, Troy, NY
dc.relation.ispartofJournal of Biological Chemistry
dc.relation.urihttps://harc.rpi.edu/
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectBiology
dc.subjectChemistry and chemical biology
dc.subjectChemical and biological engineering
dc.subjectBiomedical engineering
dc.titleInteraction of Secretory Leukocyte Protease Inhibitor with HeparinInhibits Proteases Involved in Asthma
dc.typeArticle
dc.rights.holderCC BY : this license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. Credit must be given to the authors and the original work must be properly cited.
dc.creator.identifierhttps://orcid.org/0000-0003-2219-5833
dc.relation.departmentThe Linhardt Research Labs.
dc.relation.departmentThe Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS)
rpi.description.pages13563-13569
rpi.description.volume273


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Open Access
Except where otherwise noted, this item's license is described as Open Access